Skip header and navigation

2 records – page 1 of 1.

Document Type
Rapid Review
Review Code
PPE120901 RR
Question Submitted
December 9, 2020
Date Completed
December 18, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Document Type
Rapid Review
Review Code
PPE120901 RR
Question Submitted
December 9, 2020
Date Completed
December 18, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Key Findings
Moderate evidence supporting the concept that airway management and certain surgical procedures create aerosols
No definitive evidence for the transmission of SARS-CoV-2 during AGMP
Indirect evidence from SARS-CoV-1 indicates that HCW present during AGMP are at higher risk of infection, but evidence quality is very low and very difficult to generalize
The absence of definitive evidence does not equate to the absence of risk and most policy recommendations err on the side of safety for Health Care Workers
Category
Infection Prevention and Control
Subject
Aerosols
Risk
Transmission
Population
All
Clinical Setting
Ambulatory
Long Term Care
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Groot, G; Fox, L; Mueller, M. What is the risk of COVID-19 transmission during AGMP procedures? 2020 Dec 18; Document no.: PPE120901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 30 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
PH042401 RR
Question Submitted
24-Apr-2020
Date Completed
April 28, 2020
Status
3. Completed
Research Team
Public Health
Document Type
Rapid Review
Review Code
PH042401 RR
Question Submitted
24-Apr-2020
Date Completed
April 28, 2020
Status
3. Completed
Research Team
Public Health
Key Findings
Screening tools commonly include fever, respiratory symptoms (cough, shortness of breath), and epidemiological risk factors. · The sensitivity and specificity of screening questionnaires depends considerably on the items used in the questionnaire. The limited published literature demonstrates great variability in the performance of different screening tools: sensitivity ranges from 0 – 48.6 – 84.3 – 100%; specificity ranges from 64.8 – 71.3 – 89.6 – 96%). · The standard WHO symptom checklist performs poorly, with a sensitivity of 48.6%, and specificity of 89.6%. As such, half of individuals who have SARS-CoV-2 present at the time of testing will be missed by the symptom questionnaire (being either asymptomatic or presymptomatic). Depending on the population being screened the prevalence of the virus may vary widely. Given the sensitivity and specificity of the WHO symptom checklist in a population with prevalence ranging from 0.1% to 1% to 10% the positive predictive value (PPV) will be poor, range from 0.4% to 4.8% to 35%, respectively. Furthermore, the performance characteristics of the screening questionnaire may be poorer than reported if used in a setting or time of year when other respiratory viruses with similar symptoms are circulating.
Category
Diagnostics
Epidemiology
Subject
Screening
Population
All
Neonates
Infants
All Pediatrics
Clinical Setting
Ambulatory
Emergency
Long Term Care
Other
OR
Priority Level
Level 4 completed within 1 week
Cite As
Fick, F; Neudorf, C; Reeder, B; Dalidowicz, M; Mueller, M. What is the sensitivity and specificity of screening checklists and temperature checks for detecting the presence of COVID-19 in individuals? 2020 Apr 28; Document no.: PH042401 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST rapid review report)
Similar Reviews
LAB041401 RR
EPM051201 RR
Related Documents
Documents
Less detail